Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 17/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3622887 | 0.99 | HTR6 (0.53) | HTR6LMNAKAT6A | |
| SCHEMBL3622339 | 0.92 | HTR6 (0.55) | HTR6LMNAKAT6A | |
| Hydrochloric Acid SCHEMBL3622014 | 0.91 | HTR6 (0.54) | HTR6LMNAKAT6A | |
| SCHEMBL3623801 | 0.91 | MAPT (0.47) | HTR6LMNA | |
| Hydrochloric Acid SCHEMBL3623155 | 0.90 | MAPT (0.46) | HTR6 | |
| Hydrochloric Acid SCHEMBL3625041 | 0.89 | RAD52 (0.53) | HTR6 | |
| SCHEMBL3625209 | 0.85 | HTR6 (0.48) | HTR6 | |
| Hydrochloric Acid SCHEMBL3617005 | 0.84 | HTR6 (0.47) | HTR6 | |
| SCHEMBL3622751 | 0.84 | HTR6 (0.63) | HTR6LMNAKAT6A | |
| SCHEMBL3616826 | 0.83 | HTR6 (0.50) | HTR6LMNAKAT6A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1406884-A1 | ARYLSUSFONAMIDE COMPOUNDS FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS-DISORDERS | BIOVITRUM AB (SE) | 2004-04-14 | — | — | EP | disclosed |
| WO-2002092585-A1 | NOVEL, ARYLSUSFONAMIDE COMPOUNDS FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS-DISORDERS | BIOVITRUM AB (SE) | 2002-11-21 | — | — | WO | disclosed |